Designed to build on the existing strengths of Aspetar and the National Sports Medicine Program (NSMP), ASPREV intends to form collaborative relationships with individuals, institutions and organisations both locally, regionally and internationally to implement applied, ongoing and novel research developed within the framework and long-term strategy of both the Fédération Internationale de Football Association (FIFA) and the International Olympic Committee (IOC). ASPREV’s research on epidemiology, risk factors and injury mechanisms for football injuries is based on data routinely collected from Aspetar’s numerous clinical departments and their research, including the Athlete Screening Department’s annual Periodic Health Examination (PHE), which targets key groups of athletes to look for any risk factors for injury or illness. PHE data has been captured on 559 players since its implementation in 2013, offering ASPREV a very significant insight into a large group of athletes.
In addition, a surveillance programme (FLFC) has been established to collect injury and exposure data covering QSL athletes, and is currently being expanded to also monitor sleep and wellness.
By setting up knowledge translation mechanisms to share scientific research results, ASPREV enables the implementation of injury and illness prevention strategies within the clubs based on the F-MARC risk management model, and facilitated by feedback of relevant data from the PHE and FLFC, allowing each club to compare their experience to benchmark data from the QSL and elsewhere.